Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

Zolpidem

zolpidem
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Zolpimist SPRAY, ORAL 5 mg/spray      
Ambien CR TABLET, EXTENDED RELEASE, ORAL 6.25 mg, 12.5 mg    
Ambien TABLET, ORAL 5 mg, 10 mg      
Intermezzo TABLET, SUBLINGUAL 1.75 mg, 3.5 mg    
Edluar TABLET, SUBLINGUAL 5 mg, 10 mg    


Comments:

ORDERED FORMULATION

FORMULARY INTERCHANGE

zolpidem (Ambien CR)

  • 6.25 mg extended release tablet oral

 

  • 12.5 mg extended release tablet oral

 

zolpidem (Ambien)

  • 5 mg tablet oral
    • Lunesta may be used as an alternative, if a drug with a longer half-life is needed.
  • 10 mg tablet oral
    • Lunesta may be used as an alternative, if a drug with a longer half-life is needed. If female, convert to 5 mg unless higher dose is used chronically.

zolpidem (Edluar)

  • 5 mg tablet sublingual
  • 10 mg tablet sublingual

zolpidem (Ambien)

  • 5 mg tablet oral
  • 10 mg tablet oral
    • If female, convert to 5 mg unless higher dose is used chronically.

zolpidem (Intermezzo)

  • 1.75 mg tablet sublingual
  • 3.5 mg tablet sublingual

zolpidem (Ambien)

  • 5 mg tablet oral
  • 5 mg tablet oral

Ambien medication guide

Ambien CR medication guide

Edluar medication guide

Intermezzo medication guide

Zolpimist medication guide


Ambien CR is non-formulary, not stocked. Interchange to regular zolpidem. Lunesta can be used as a back-up drug (non-benzodiazepine with a longer half-life) if needed.

Due to new FDA dosing recommendations, P&T approved a dose adjustment from zolpidem 10 mg to 5 mg for female patients, if the medication was started in the hospital. The dose should not be adjusted for female patients that have taken 10 mg as a chronic outpatient medication. Reviewed: April 23, 2013

ZOLPIMIST is classified as NON-FORMULARY, NOT STOCKED. Contact the physician for an alternative agent. Reviewed: February 22, 2011

EDLUAR is classified as NON-FORMULARY, NOT STOCKED. Reviewed: October 27, 2009

Reviewed: May 22, 2007 (Benzodiazepine-Related Hypnotic Formulary)


Last updated: Mar. 1, 2022







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.